中国计量大学学报

参考文献 [1] GRASSI D,DESIDERI G,CROCE G,et al.Flavonoids,vascular function and cardiovascular protection[J].Current Pharmaceutical Design,2009,15(10):1072-1084.
[2] ATRAHIMOVICH D,AVNI D,KHATIB S.Flavonoids-macromolecules interactions in human diseases with focus on alzheimer,atherosclerosis and cancer[J].Antioxidants,2021,10(3):423(1-15).
[3] GONG L,LEI Y,LIU Y,et al.Vaccarin prevents ox-LDL-induced HUVEC EndMT,inflammation and apoptosis by suppressing ROS/p38 MAPK signaling[J].American Journal of Translational Research,2019,11(4):2140-2154.
[4] WANG D,OZEN C,ABU-REIDAH I M,et al.Vasculoprotective effects of pomegranate (Punica granatum L.)[J].Frontiers in Pharmacology,2018,9(9):544(1-15).
[5] MAHMOUD A M,HEMANDEZ BAUTISTA R J,SANDHO M A,et al.Beneficial effects of citrus flavonoids on cardiovascular and metabolic health[J].Oxidative Medicine and Cellular Longevity,2019,2019:5484138(1-19).
[6] JIA Q,CAO H,SHEN D,et al.Quercetin protects against atherosclerosis by regulating the expression of PCSK9,CD36,PPAR gamma,LXR alpha and ABCA1[J].International Journal of Molecular Medicine,2019,44(3):893-902.
[7] LILA M A.Anthocyanins and human health:an in vitro investigative approach[J].Journal of Biomedicine & Biotechnology,2004(5):306-313.
[8] PROCHAZKOVA D,BOUSOVA I,WIHELMOVA N.Antioxidant and prooxidant properties of flavonoids[J].Fitoterapia,2011,82(4):513-523.
[9] RUSSO A,ACQUAVIVA R,CAMPISI A,et al.Bioflavonoids as antiradicals,antioxidants and DNA cleavage protectors[J].Cell Biology and Toxicology,2000,16(2):91-8.
[10] FARZAEI M H,SINGH A K,KUMAR R,et al.Targeting inflammation by flavonoids:novel therapeutic strategy for metabolic disorders[J].International Journal of Molecular Sciences,2019,20(19):4957(1-39).
[11] CROZIER A,JAGANATH I B,CLIFFORD M N.Dietary phenolics:Chemistry,bioavailability and effects on health[J].Natural Product Reports,2009,26(8):1001-1043.
[12] FANG H T,LIU H Y,MA R S,et al.Genome-wide assessment of population structure and genetic diversity of Chinese Lou onion using specific length amplified fragment (SLAF) sequencing[J].Plos One,2020,15(5):0231753(1-14).
[13] MENGIST M F,GRACE M H,XIONG J,et al.Diversity in metabolites and fruit quality traits in blueberry enables ploidy and species differentiation and establishes a strategy for future genetic studies[J].Frontiers in Plant Science,2020,11(11):1-17.
[14] REDFORD K E,ABBOTT G W.The ubiquitous flavonoid quercetin is an atypical KCNQ potassium channel activator[J].Communications Biology,2020,3(1):1-15.
[15] 曾艺芸，聂雪婷，李振坚，等.中药石斛黄酮活性成分研究进展[J].中国实验方剂学杂志，2021,27(6):197-206.ZENG Y Y,NIE X T,LI Z J,et al.Research progress on active ingredients of flavonoids in traditional chinese medicine dendrobium[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(6):197-206.
[16] 姚雪，吴国真，赵宏伟，等.黄芩中化学成分及药理作用研究进展[J].辽宁中医杂志，2020,47(7):215-220.YANG X,WU G Z,ZHAO H W,et al.Study advances on chemical constituents and pharmacological effects of huangqin[J].Liaoning Journal of Traditional Chinese Medicine,2020,47(7):215-220.
[17] PANCHE A N,DIWAN A D,CHANDRA S R.Flavonoids:An overview[J].Journal Nutritional Science,2016,5:1-15.
[18] 何珊，姜勇，屠鹏飞.肉桂的化学成分研究[J].中国中药杂志，2015,40(18):3598-3602.HE S,JIANG Y,TU P F.Chemical constituents from cinnamomum cassia[J].China Journal of Chinese Materia Medica,2015,40(18):3598-3602.
[19] 张燕，熊波，易娜，等.黄烷醇类化合物的药理活性研究进展[J].食品安全质量检测学报，2015,6(3):1055-1060.ZHANG Y,XIONG B,YI N,et al.Advances in research on pharmacological activities of flavanol compounds[J].Journal of Food Safety & Quality,2015,6(3):1055-1060.
[20] 赵晶，李彦杰，周厚勤，等.甲基麦冬黄烷酮A降低缺氧复氧诱导PC12细胞凋亡及氧化损伤[J].中成药，2020,42(1):213-216.ZHAO J,LI Y J,ZHOU H Q,et al.Methyl ophiflavanone A reduces hypoxia/reoxygenation-induced apoptosis and oxidative damage in PC12 cells[J].Chinese Traditional Patent Medicine,2020,42(1):213-216.
[21] 郑云枫，李洋，段伟萍，等.一测多评法测定黄芪中异黄酮及苷类成分[J].中草药，2021,52(10):3104-3111.ZHENG Y F,LI Y,DUAN W P,et al.Determination of isoflavonoids and glycosides in Astragali Radix by QAMS method[J].Chinese Traditional and Herbal Drugs,2021,52(10):3104-3111.
[22] 李娜，王平，孙铁锋，等.半枝莲化学成分、药理作用及质量控制研究进展[J].中国中药杂志，2020,45(21):5117-5128.LI N,WANG P,SUN T F,et al.Research progress on chemical constituents,pharmacological action and quality control of Scutellaria barbata[J].China Journal of Chinese Materia Medica,2020,45(21):5117-5128.
[23] ALAPPAT B,ALAPPAT J.Anthocyanin pigments:Beyond aesthetics[J].Molecules,2020,25(23):1-17.
[24] RIBNICKY D M,ROOPCHAND D E,OREN A,et al.Effects of a high fat meal matrix and protein complexation on the bioaccessibility of blueberry anthocyanins using the TNO gastrointestinal model (TIM-1)[J].Food Chemistry,2014,142:349-357.
[25] KHOO H E,AZLAN A,TANG S T,et al.Anthocyanidins and anthocyanins:colored pigments as food,pharmaceutical ingredients,and the potential health benefits[J].Food & Nutrition Research,2017,61:1-21.
[26] WENZEL P,KOSSMANN S,MUNZEL T,et al.Redox regulation of cardiovascular inflammation - Immunomodulatory function of mitochondrial and Nox-derived reactive oxygen and nitrogen species[J].Free Radical Biology and Medicine,2017,109:48-60.
[27] KACKOV S,SIMUNDIC A M,NIKOLAC N,et al.The effect of high-calorie meal consumption on oxidative stress and endothelial dysfunction in healthy male adults[J].Physiological Research,2013,62(6):643-52.
[28] 陈惠，胡勇.花青素通过上调Nrf2/HO-1途径抑制H2O2诱导脐静脉内皮细胞氧化损伤的研究[J].中医药临床杂志，2019,31(5):911-915.CHEN H,HU Y.Protective effect of anthocyanin on vascular endothelial injury induced by H2O2 via Nrf2/HO-1 signaling pathway[J].Clinical Journal of Traditional Chinese Medicine,2019,31(5):911-915.
[29] LUO Y,LU S,DONG X,et al.Dihydromyricetin protects human umbilical vein endothelial cells from injury through ERK and Akt mediated Nrf2/HO-1 signaling pathway[J].Apoptosis,2017,22(8):1013-1024.
[30] WU Y,SONG F,LI Y D,et al.Acacetin exerts antioxidant potential against atherosclerosis through Nrf2 pathway in apoE(-/-) Mice[J].Journal of Cellular and Molecular Medicine,2021,25(1):521-534.
[31] HU Y W,LI H T,LI R L,et al.Puerarin protects vascular smooth muscle cells from oxidized low-density lipoprotein-induced reductions in viability via inhibition of the p38 MAPK and JNK signaling pathways[J].Experimental and Therapeutic Medicine,2020,20(6):270(1-6).
[32] GE W,ZHAO K,WANG X,et al.iASPP is an antioxidative factor and drives cancer growth and drug resistance by competing with Nrf2 for Keap1 binding[J].Cancer Cell,2017,32(5):561-573.
[33] ISHII T,TAKAHASHI S,SATO H,et al.Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages[J].The Journal of Biological Chemistry,2000,275(21):16023-16029.
[34] KANG M-I,KOBAYASHI A,WAKABAYASHI N,et al.Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genes[J].Proceedings of the National Academy of Sciences of the United States of America,2004,101(7):2046-2051.
[35] KOBAYASHI A,KANG M I,OKAWA H,et al.Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2[J].Molecular and Cellular Biology,2004,24(16):7130-7139.
[36] NIOI P,MCMAHON M,ITOH K,et al.Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidoreductase 1 gene:reassessment of the ARE consensus sequence[J].The Biochemical Journal,2003,374:337-348.
[37] KWAK M K,WAKABAYASHI N,KENSLER T W.Chemoprevention through the Keap1-Nrf2 signaling pathway by phase 2 enzyme inducers[J].Mutation Research,2004,555(1-2):133-148.
[38] ALI M Y,ZAIB S,RAHMAN M M,et al.Didymin,a dietary citrus flavonoid exhibits anti-diabetic complications and promotes glucose uptake through the activation of PI3K/Akt signaling pathway in insulin-resistant HepG2 cells[J].Chemico-Biological Interactions,2019,305:180-194.
[39] HE P,YAN S,WEN X,et al.Eriodictyol alleviates lipopolysaccharide-triggered oxidative stress and synaptic dysfunctions in BV-2microglial cells and mouse brain[J].Journal of Cellular Biochemistry,2019,120(9):14756-14770.
[40] JOHNSON J,MAHER P,HANNEKEN A.The flavonoid,eriodictyol,induces long-term protection in ARPE-19 cells through its effects on Nrf2 activation and phase 2 gene expression[J].Investigative Ophthalmology & Visual Science,2009,50(5):2398-2406.
[41] KULASEKARAN G,GANAPASAM S.Neuroprotective efficacy of naringin on 3-nitropropionic acid-induced mitochondrial dysfunction through the modulation of Nrf2 signaling pathway in PC12 cells[J].Molecular and Cellular Biochemistry,2015,409(1-2):199-211.
[42] LEE S E,YANG H,SON G W,et al.Eriodictyol protects endothelial cells against oxidative stress-induced cell death through modulating ERK/Nrf2/ARE-dependent heme oxygenase-1 expression[J].International Journal of Molecular Sciences,2015,16(7):14526-14539.
[43] LEE Y Y,LEE E J,PARK J S,et al.Anti-Inflammatory and antioxidant mechanism of tangeretin in activated microglia[J].Journal of Neuroimmune Pharmacology,2016,11(2):294-305.
[44] LIANG F,FANG Y,CAO W,et al.Attenuation of tert-Butyl hydroperoxide (t-BHP)-induced oxidative damage in HepG2 cells by tangeretin:Relevance of the Nrf2-ARE and MAPK signaling pathways[J].Journal of Agricultural and Food Chemistry,2018,66(25):6317-6325.
[45] XU D,HU M J,WANG Y Q,et al.Antioxidant activities of quercetin and its complexes for medicinal application[J].Molecules,2019,24(6):1123(1-15).
[46] SIASOS G,TOUSOULIS D,KIOUFIS S,et al.Inflammatory mechanisms in atherosclerosis:The impact of matrix metalloproteinases[J].Current Topics in Medicinal Chemistry,2012,12(10):1132-1148.
[47] CHEN Y C,SHEN S C,LEE W R,et al.Inhibition of nitric oxide synthase inhibitors and lipopolysaccharide induced inducible NOS and cyclooxygenase-2 gene expressions by rutin,quercetin,and quercetin pentaacetate in RAW 264.7macrophages[J].Journal of Cellular Biochemistry,2001,82(4):537-548.
[48] KUTIL Z,TEMMLl V,MAGHRADZE D,et al.Impact of wines and wine constituents on cyclooxygenase-1,cyclooxygenase-2,and 5-lipoxygenase catalytic activity[J].Mediators Inflamm,2014,2014:178931(1-8).
[49] ZHAO H,LIU M,LIU H.et al.Naringin protects endothelial cells from apoptosis and inflammation by regulating the Hippo-YAP Pathway[J].Bioscience Reports,2020,40(3):BSR20193431(1-10).
[50] MACKENZIE G G,CARRASQUEDO F,DELFINO J M,et al.Epicatechin,catechin,and dimeric procyanidins inhibit PMA-induced NF-kappaB activation at multiple steps in Jurkat T cells[J].FASEB Journal:Official Publication of the Federation of American Societies for Experimental Biology,2004,18(1):167-169.
[51] CHO S Y,PARK S J,KWON M J,et al.Quercetin suppresses proinflammatory cytokines production through MAP kinases andNF-kappaB pathway in lipopolysaccharide-stimulated macrophage[J].Molecular and Cellular Biochemistry,2003,243(1-2):153-160.
[52] ED NIGNPENSE B,CHINKWO K A,BLANCHARD C L,et al.Polyphenols:Modulators of platelet function and platelet microparticle generation?[J].International Journal of Molecular Sciences,2019,21(1):146(1-19).
[53] GOSZCZ K,DUTHIE G G,STEWART D,et al.Bioactive polyphenols and cardiovascular disease:Chemical antagonists,pharmacological agents or xenobiotics that drive an adaptive response?[J].British Journal of Pharmacology,2017,174(11):1209-1225.
[54] ARTS I C,HOLLMAN P C.Polyphenols and disease risk in epidemiologic studies[J].The American Journal of Clinical Nutrition,2005,81:317-325.
[55] WRIGHT B,MORAES L A,KEMP C F,et al.A structural basis for the inhibition of collagen-stimulated platelet function by quercetin and structurally related flavonoids[J].British Journal of Pharmacology,2010,159(6):1312-1325.
[56] KHAN H,JAWAD M,KAMAL M A,et al.Evidence and prospective of plant derived flavonoids as antiplatelet agents:Strong candidates to be drugs of future[J].Food and Chemical Toxicology,2018,119:355-367.
[57] GUERRERO J A,LOZANO M L,CASTILLO J,et al.Flavonoids inhibit platelet function through binding to the thromboxane A2 receptor[J].Journal of Thrombosis and Haemostasis:JTH,2005,3(2):369-376.
[58] NAVARRO-NUNEZ L,CASTILLO J,LOZANO M L,et al.Thromboxane A2 receptor antagonism by flavonoids:Structure-activity relationships[J].Journal of Agricultural Food Chemistry,2009,57(4):1589-1594.
[59] ZARAGOZA C,MONSERRAT J,MANTECON C,et al.Binding and antiplatelet activity of quercetin,rutin,diosmetin,and diosmin flavonoids[J].Biomed Pharmacother,2021,141:111867(1-8).
[60] TIAN Z,LI K,FAN D,et al.Dose-dependent effects of anthocyanin supplementation on platelet function in subjects with dyslipidemia:A randomized clinical trial[J].EBioMedicine,2021,70:103533(1-10).
[61] BOJIC M,ANTOLIC A,TOMICIC M,et al.Propolis ethanolic extracts reduce adenosine diphosphate induced platelet aggregation determined on whole blood[J].Nutrition Journal,2018,17(1):52(1-8).
[62] RO J Y,RYU J H,PARK H J,et al.Onion (Allium cepa L.) peel extract has anti-platelet effects in rat platelets[J].SpringerPlus,2015,4(1):17(1-8).
[63] ZARAGOZA C,ALVAREZ-MON M A,ZARAGOZA F,et al.Flavonoids:Antiplatelet effect as inhibitors of COX-1[J].Molecules,2022,27(3):1146(1-13).
[64] MAJITHIA A,BHATT D L.Novel antiplatelet therapies for atherothrombotic diseases[J].Arteriosclerosis Thrombosis and Vascular Biology,2019,39(4):546-557.
[65] HUBBARD G P,STEVENS J M,CICMIL M,et al.Quercetin inhibits collagen-stimulated platelet activation through inhibition of multiple components of the glycoprotein VI signaling pathway[J].Journal of Thrombosis and Haemostasis:JTH,2003,1(5):1079-1088.
[66] MOE G W,ROULEAU J L,NGUYEN Q T,et al.Role of endothelins in congestive heart failure[J].Canadin Journal of Physiology and Pharmacology,2003,81(6):588-597.
[67] STEFANADI E,TOUSOULIS D,ANDROULAKIS E S,et al.Inflammatory markers in essential hypertension:Potential clinical implications[J].Current Vascular Pharmacology,2010,8(4):509-516.
[68] SIASOS G,TOUSOULIS D,VLACHOPOULOS C,et al.The impact of oral L-arginine supplementation on acute smoking-induced endothelial injury and arterial performance[J].American Journal of Hypertension,2009,22(6):586-592.
[69] OIKONOMOU E,TOUSOULIS D,SIASOS G,et al.The role of inflammation in heart failure:New therapeutic approaches[J].Hellenic Journal of Cardiology,2011,52(1):30-40.
[70] TOUSOULIS D,OIKONOMOU E,SIASOS G,et al.Predictive value of biomarkers in patients with heart failure[J].Current Medicinal Chemistry,2012,19(16):2534-2547.
[71] TOUSOULIS D,KAMPOLI A M,SIASOS G,et al.Circulating biomarkers for the diagnosis and prognosis of heart failure[J].Current Medicinal Chemistry,2009,16(29):3828-3840.
[72] TOUSOULIS D,ANTONIADES C,NIKOLOPOULOU A,et al.Interaction between cytokines and sCD40L in patients with stable and unstable coronary syndromes[J].European Journal of Clinical Investigation,2007,37(8):623-628.
[73] XU Y C,LEUNG S W,YEUNG D K,et al.Structure-activity relationships of flavonoids for vascular relaxation in porcine coronary artery[J].Phytochemistry,2007,68(8):1179-1188.
[74] YANG D,YANG Z,CHEN L,et al.Dihydromyricetin increases endothelial nitric oxide production and inhibits atherosclerosis through microRNA-21 in apolipoprotein E-deficient mice[J].Journal of Cellular and Molecular Medicine,2020,24(10):5911-5925.
[75] CHEN C P,CHAN K C,HO H H,et al.Mulberry polyphenol extracts attenuated senescence through inhibition of Ras/ERK via promoting Ras degradation in VSMC[J].International Journal of Medical Sciences,2022,19(1):89-97.
[76] ASSUNCAO H C R,CRUZ Y M C,BERTOLINO J S,et al.Protective effects of luteolin on the venous endothelium[J].Molecular and Cellular Biochemistry,2021,476(4):1849-1859.
[77] DASH S,XIAO C T,MORGANTINI C,et al.New insights into the regulation of chylomicron production[J].Annual Review of Nutrition,2015,35(1):265-294.
[78] 杨光，杜云龙，朱开梅，等.定心藤总黄酮对高脂血症大鼠降血脂的作用研究[J].重庆医学，2017,46(4):433-435,438.YANG G,DU Y L,ZHU K M,et al.Effects of decreasing lipidemia by mappianthus iodoies flavone in SD rats[J].Chongqing Medicine,2017,46(4):433-435,438.
[79] BORRADAILE N M,DE DREU L E,BARRETT P H R,et al.Hepatocyte apoB-containing lipoprotein secretion is decreased by the grapefruit flavonoid,naringenin,via inhibition of MTP-mediated microsomal triglyceride accumulation[J].Biochemistry,2003,42(5):1283-1291.
[80] BORRADAILE N M,DE DREU L E,BARRETT P H R,et al.Inhibition of hepatocyte apoB secretion by naringenin:enhanced rapid intracellular degradation independent of reduced microsomal cholesteryl esters[J].Journal of Lipid Research,2002,43(9):1544-1554.
[81] GRAGNANO F,CALABRO P.Role of dual lipid-lowering therapy in coronary atherosclerosis regression:Evidence from recent studies[J].Atherosclerosis,2018,269:219-228.
[82] VALANTI E-K,DALAKOURA-KARAGKOUNI K,SIASOS G,et al.Advances in biological therapies for dyslipidemias and atherosclerosis[J].Metabolism-Clinical and Experimental,2021,116(1):154461(1-10).
[83] SANTISTEBAN M M,QI Y,ZUBCEVIC J,et al.Hypertension-Linked Pathophysiological Alterations in the Gut[J].Circulation Research,2017,120(2):312-323.
[84] CHEN W Y,WANG M,ZHANG J,et al.Acrolein disrupts tight junction proteins and causes endoplasmic reticulum stress-mediated epithelial cell death leading to intestinal barrier dysfunction and permeability[J].The American Journal of Pathology,2017,187(12):2686-2697.
[85] MITRA S,DRAUTZ-MOSES D I,ALHEDE M,et al.In silico analyses of metagenomes from human atherosclerotic plaque samples[J].Microbiome,2015,3:38(1-14).
[86] MAS-CAPDEVILA A,TEICHENNE J,DOMENECH-COCA C,et al.Effect of hesperidin on cardiovascular disease risk factors:The role of intestinal microbiota on hesperidin bioavailability[J].Nutrients,2020,12(5):1488(1-27).
[87] YANG S,ZHANG Y,LI W,et al.Gut microbiota cmposition affects procyanidin A2-attenuated atherosclerosis in ApoE(-/-) mice by modulating the bioavailability of its microbial metabolites[J].Journal of Agricultural and Food Chemistry,2021,69(25):6989-6999.